| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 7 | 345,377 | SION, ZBIO, IMNM, BBOT | 13F-HR | 8/14/2026 | 000195310726000012 |
| Q1 2026 | 7 | 351,507 | SION, IMNM, ZBIO, CMPX | 13F-HR | 5/15/2026 | 000195310726000008 |
| Q4 2025 | 7 | 506,782 | ZBIO, IMNM, SION, UPB | 13F-HR | 2/17/2026 | 000195310726000003 |
| Q3 2025 | 7 | 327,524 | ZBIO, SION, IMNM, UPB | 13F-HR | 11/14/2025 | 000195310725000014 |
| Q2 2025 | 6 | 176,535 | IMNM, SION, ZBIO, UPB | 13F-HR | 8/14/2025 | 000141588925021852 |
| Q1 2025 | 6 | 132,721 | IMNM, ZBIO, SIONNA THERAPEUTICS INC, CAMP | 13F-HR | 5/15/2025 | 000141588925013132 |
| Q4 2024 | 5 | 139,236 | UPSTREAM BIO INC, IMNM, ZBIO, CAMP4 THERAPEUTICS CORP | 13F-HR | 2/14/2025 | 000110465925014094 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.
| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
|
Sionna Therapeutics, Inc.
13D
SION · 829401108
|
5.6% |
2/18/2025
Event 2/10/2025
|
||||
| Enavate Sciences GP, LLC | 5.6% | |||||
| Sionna Aggregator, LP | 5.6% | |||||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||||
|
Zenas BioPharma, Inc.
13D/A
ZBIO · 98937L105
|
4.9% |
8/19/2026
Event 8/19/2026
|
||||
| Enavate Sciences GP, LLC | 4.9% | |||||
| Zebra Aggregator, LP | 4.9% | |||||
|
CAMP4 Therapeutics Corporation
13D/A
CAMP · 13463J101
|
4.8% |
3/11/2026
Event 3/9/2026
|
||||
| Enavate Sciences GP, LLC | 4.8% | |||||
| Everest Aggregator, LP | 4.8% | |||||
|
Immunome, Inc.
13D/A
IMNM · 45257U108
|
4.3% |
12/22/2025
Event 12/18/2025
|
||||
| Enavate Sciences GP, LLC | 4.3% | |||||
| Immunome Aggregator, LP | 4.3% | |||||